IDEXX is launching its canine lymphoma test internationally in H1 2026 and adding mast cell tumor detection in North America, signaling significant investment in global go-to-market strategies, regulatory approvals, and R&D.
Filing excerpt
During 2025, we launched the IDEXX Cancer Dx Panel in North America, which is a simple blood test for dogs that screens for lymphoma, and will expand the IDEXX Cancer Dx Panel to include canine mast cell tumor detection in North America in 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kmarketExpansionGet every 10-K signal for Idexx Laboratories and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Idexx Laboratories this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0535b6d2-006e-462a-bb1d-e3dbd7ac5762 returns this record as JSON. POST /v1/companies/enrich returns every signal for idexx.com.
{
"signal_id": "0535b6d2-006e-462a-bb1d-e3dbd7ac5762",
"signal_type": "sec-10k",
"signal_subtype": "marketExpansion",
"detected_at": "2026-02-24T09:21:44.135+00:00",
"company": {
"name": "Idexx Laboratories",
"domain": "idexx.com"
},
"data": {
"detail": "IDEXX is launching its canine lymphoma test internationally in H1 2026 and adding mast cell tumor detection in North America, signaling significant investment in global go-to-market strategies, regulatory approvals, and R&D.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Expanding Cancer Dx Panel internationally and adding new detection capabilities in 2026",
"excerpts": "During 2025, we launched the IDEXX Cancer Dx Panel in North America, which is a simple blood test for dogs that screens for lymphoma, and will expand the IDEXX Cancer Dx Panel to include canine mast cell tumor detection in North America in 2026.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market",
"regions_mentioned": [
"North America"
]
}
}
curl https://signals.autobound.ai/v1/signals/0535b6d2-006e-462a-bb1d-e3dbd7ac5762 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.